SG Americas Securities’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,203
Closed -$888K 3671
2025
Q4
$888K Buy
76,203
+66,098
+654% +$643K ﹤0.01% 2111
2025
Q3
$102K Sell
10,105
-15,196
-60% -$218K ﹤0.01% 3077
2025
Q2
$442K Sell
25,301
-11,125
-31% -$161K ﹤0.01% 1757
2025
Q1
$458K Sell
36,426
-14,776
-29% -$178K ﹤0.01% 1853
2024
Q4
$540K Sell
51,202
-7,102
-12% -$99.5K ﹤0.01% 1267
2024
Q3
$845K Sell
58,304
-53,288
-48% -$634K ﹤0.01% 1216
2024
Q2
$950K Buy
111,592
+99,986
+862% +$887K 0.01% 1325
2024
Q1
$119K Buy
+11,606
New +$86.5K ﹤0.01% 2421
2022
Q1
Sell
-11,405
Closed -$76K 3400
2021
Q4
$76K Sell
11,405
-2,053
-15% -$16.7K ﹤0.01% 3137
2021
Q3
$134K Buy
13,458
+6,917
+106% +$171K ﹤0.01% 3508
2021
Q2
$202K Buy
+6,541
New +$210K ﹤0.01% 2335
2021
Q1
Sell
-12,900
Closed -$598K 3534
2020
Q4
$598K Buy
+12,900
New +$431K ﹤0.01% 1852

Other funds holding SPRY